Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The generation of an HIV vaccine remains the holy grail for eliminating HIV infection worldwide. Major advances in 2018 centred on sequential multi-immunogen strategies that are designed to induce broadly neutralizing antibodies, identifying new targets and defining new approaches to immunogen evaluation.
In 2017, epidemiological studies in humans and experiments in mouse models showed that the intestinal microbiota determines the effectiveness of anticancer immunotherapies. As such the microbiota offers new prognostic biomarkers and shows promise as a target for future antineoplastic treatments.
Monocytes and tissue macrophages represent two main branches of the mononuclear phagocyte system, and they have complementary roles during immunological challenges. Several studies published in 2017 highlighted the distinct properties of these two cell types and furthered our understanding of their development and cellular functions.